Opinions Robert Floyd
King PharmaceuticalsKGBUYAug 16, 2002
Cheap/ Good growth prospects. Only own a small portion in your portfolio.
Robert FloydUnknown
$19.38
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Has great value. US Healthcare looks very inexpensive.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Will be volatile. An OK company at a bargain price. Good risk/reward.
Peter Arender, CFAOwned
biotechnologypharmaceutical
TOP PICK
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
Brian Acker, CAOwned
biotechnologypharmaceutical
Popular Articles
Most Recent Experts
The Weekly Buzzing Stocks by Billy Kawasaki
Stockchase
Joe Terranova
Virtus Investment Partners
Stephen Weiss, Founder, Short Hills Capital Partners
Short Hills Capital Partners
Rob Sechan, Managing Partner, New Edge Capital
New Edge Capital
Jason Snipe, CIO, Odyssey Capital Advisors
Odyssey Capital Advisors